A clinical trial regional director filed a $2 billion lawsuit against Pfizer and BioNTech alleging the pharmaceutical companies fabricated and falsified their covid-19 vaccine trial data. The lawsuit was unsealed today after being filed on January 8, 2021.
Developing a safe and effective vaccine against the novel Coronavirus (“COVID-
19”) was a matter of urgency. But that urgency does not excuse cutting corners in clinical trials,
wasting taxpayer dollars, violating federal regulations, and possibly endangering Americans’
health. Defendants Pfizer Inc., Icon PLC, and Ventavia Research Group, LLC (collectively,
“Defendants”) conducted a clinical trial to test one of the COVID-19 vaccine candidates. In the
race to secure billions in federal funding and become the first to market, Defendants deliberately
withheld crucial information from the United States that calls the safety and efficacy of their
vaccine into question. Namely, Defendants concealed violations of both their clinical trial protocol
and federal regulations, including falsification of clinical trial documents. Due to Defendants’
scheme, millions of Americans have received a misbranded vaccination which is potentially not
as effective as represented. The vaccine’s U.S. Food and Drug Administration (“FDA”)
authorization resulted from a deeply flawed clinical trial that violated FDA regulations.
Defendants have profited from the COVID-19 pandemic at the expense of the United States and
its citizens by abusing the scientific process….